Below is Validea's guru fundamental report for ROBLOX CORP (RBLX). Of the 22 guru strategies we follow, RBLX rates highest using our Quantitative Momentum Investor model based on the published ...
SEONGNAM, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced a global licensing agreement with Eli Lilly and ...
Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a phase 1 candidate for metabolic-associated steatohepatitis (MASH) and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback